Intra Cellular Therapies shares owned by State of New Jersey Common Pension Fund D
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by State of New Jersey Common Pension Fund D
from 13F filings
Historical chart of State of New Jersey Common Pension Fund D investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by State of New Jersey Common Pension Fund D consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Intra Cellular Therapies by State of New Jersey Common Pension Fund D
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $4.4M | 33k | 131.92 |
| 2024-12-31 | $3.1M | 37k | 83.52 |
| 2024-09-30 | $2.6M | 36k | 73.17 |
| 2024-06-30 | $2.4M | 36k | 68.49 |
| 2024-03-31 | $3.6M | 52k | 69.20 |
| 2023-12-31 | $3.8M | 52k | 71.62 |
| 2023-09-30 | $2.7M | 52k | 52.09 |
| 2023-06-30 | $3.5M | 55k | 63.32 |
| 2023-03-31 | $3.0M | 55k | 54.15 |
| 2022-12-31 | $2.9M | 55k | 52.92 |
| 2022-09-30 | $2.5M | 53k | 46.54 |
| 2022-06-30 | $3.0M | 53k | 57.08 |
| 2022-03-31 | $3.2M | 53k | 61.20 |
| 2021-12-31 | $3.7M | 70k | 52.35 |
| 2021-09-30 | $3.4M | 92k | 37.29 |
| 2021-06-30 | $2.7M | 67k | 40.82 |
| 2021-03-31 | $2.2M | 64k | 33.93 |
| 2020-12-31 | $2.6M | 82k | 31.80 |
| 2020-06-30 | $2.2M | 84k | 25.67 |
| 2017-06-30 | $776k | 63k | 12.42 |
| 2017-03-31 | $1.0M | 63k | 16.26 |
| 2016-12-31 | $943k | 63k | 15.09 |
| 2016-09-30 | $953k | 63k | 15.25 |
| 2016-06-30 | $2.4M | 63k | 38.82 |
| 2016-03-31 | $1.7M | 63k | 27.81 |
| 2015-12-31 | $3.4M | 63k | 53.79 |
| 2015-09-30 | $2.5M | 63k | 40.05 |
| 2015-06-30 | $1.4M | 45k | 31.96 |
| 2015-03-31 | $1.1M | 45k | 23.89 |
| 2014-12-31 | $794k | 45k | 17.64 |
| 2014-09-30 | $617k | 45k | 13.71 |
| 2014-06-30 | $759k | 45k | 16.87 |
More positions owned by State of New Jersey Common Pension Fund D
View all positions for State of New Jersey Common Pension Fund D
Top funds holding Intra Cellular Therapies
View all funds holding Intra Cellular Therapies